Walgreens (WAG) Comps Down 8.2% in August; Sales Fell 4.5%
Tweet Send to a FriendGet Alerts WAG Hot Sheet
Price: $50.90 --0%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 2.2%
Revenue Growth %: 0.0%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 2.2%
Revenue Growth %: 0.0%
Trade WAG Now!
Walgreens (NYSE: WAG) had August sales of $5.85 billion, a decrease of 4.5 percent from $6.12 billion for the same month in fiscal 2011.
Total front-end sales increased 0.9 percent compared with the same month in 2011, while comparable store front-end sales decreased 0.6 percent. Customer traffic in comparable stores decreased 2.2 percent while basket size increased 1.6 percent.
Prescriptions filled at comparable stores decreased 6.8 percent in August. Higher incidence of flu positively impacted comparable store prescriptions filled by 0.4 percentage point. The negative impact on comparable store prescriptions filled due to not being part of the Express Scripts, Inc. pharmacy network was 10.7 percentage points in August. Prescriptions processed by Express Scripts comprised 12.6 percent of Walgreens prescriptions in August 2011.
August pharmacy sales decreased 7.2 percent, while comparable store pharmacy sales decreased 12.4 percent. Comparable store pharmacy sales were negatively impacted by 7.9 percentage points due to generic drug introductions in the last 12 months and by 10.7 percentage points due to not being part of the Express Scripts network in August. Pharmacy sales accounted for 64.1 percent of total sales for the month.
Sales in comparable stores decreased by 8.2 percent in August. The effect of generic drug introductions in the last 12 months negatively impacted total comparable sales by 5.1 percentage points.
Total sales for the fourth quarter of fiscal 2012, which ended Aug. 31, were $17.08 billion, down 4.9 percent from $17.97 billion in last year’s quarter. Comparable store sales for the fourth quarter of fiscal 2012 decreased 8.7 percent, while front-end comparable store sales for the quarter decreased 1.3 percent. Prescriptions filled at comparable stores decreased 8.0 percent in the fourth quarter and comparable pharmacy sales decreased 12.6 percent.
Calendar year-to-date sales were $46.49 billion, a decrease of 3.2 percent from $48.04 billion in 2011.
Total sales for fiscal 2012 were $71.64 billion, down 0.8 percent from $72.18 billion in fiscal 2011. Comparable store sales for fiscal 2012 decreased 3.6 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Total front-end sales increased 0.9 percent compared with the same month in 2011, while comparable store front-end sales decreased 0.6 percent. Customer traffic in comparable stores decreased 2.2 percent while basket size increased 1.6 percent.
Prescriptions filled at comparable stores decreased 6.8 percent in August. Higher incidence of flu positively impacted comparable store prescriptions filled by 0.4 percentage point. The negative impact on comparable store prescriptions filled due to not being part of the Express Scripts, Inc. pharmacy network was 10.7 percentage points in August. Prescriptions processed by Express Scripts comprised 12.6 percent of Walgreens prescriptions in August 2011.
August pharmacy sales decreased 7.2 percent, while comparable store pharmacy sales decreased 12.4 percent. Comparable store pharmacy sales were negatively impacted by 7.9 percentage points due to generic drug introductions in the last 12 months and by 10.7 percentage points due to not being part of the Express Scripts network in August. Pharmacy sales accounted for 64.1 percent of total sales for the month.
Sales in comparable stores decreased by 8.2 percent in August. The effect of generic drug introductions in the last 12 months negatively impacted total comparable sales by 5.1 percentage points.
Total sales for the fourth quarter of fiscal 2012, which ended Aug. 31, were $17.08 billion, down 4.9 percent from $17.97 billion in last year’s quarter. Comparable store sales for the fourth quarter of fiscal 2012 decreased 8.7 percent, while front-end comparable store sales for the quarter decreased 1.3 percent. Prescriptions filled at comparable stores decreased 8.0 percent in the fourth quarter and comparable pharmacy sales decreased 12.6 percent.
Calendar year-to-date sales were $46.49 billion, a decrease of 3.2 percent from $48.04 billion in 2011.
Total sales for fiscal 2012 were $71.64 billion, down 0.8 percent from $72.18 billion in fiscal 2011. Comparable store sales for fiscal 2012 decreased 3.6 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Walgreens Third Quarter 2013 Earnings Release, Conference Call Scheduled for June 25
- Wells Boosts Estimates on BlackBerry (BBRY) Following Recent Checks; Maintains Outperform
- Camtek (CAMT) Wins Order from Asian OSAT Company
Create E-mail Alert Related Categories
Retail Sales
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
